Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura. (19th May 2022)

• Record Type: Journal Article
• Authors: Chanut, Mathilde; Jaidi, Rym; Kohn, Milena; Grange, Thomas; Brones, Clara; Lombion, Naëlle; Rousselot, Philippe; Longval, Thomas
• Is Part Of: Platelets. Volume 33:Number 4(2022)
• Page Start: 652
• Page End: 653
• Publication Date: 2022-05-19
• Subjects: Immune Thrombocytopenic Purpura -- mRNA SARS Cov2 vaccine -- Rechallenge; Blood platelets -- Periodicals; Blood Platelets -- Periodicals; 615.39
• DOI: 10.1080/09537104.2022.2044463
• Languages: English
• ISSNs: 0953-7104

Abstract

Abstract: In 2021, the world experienced the most extensive vaccination campaign to defeat COVID-19. Many cases of idiopathic thrombocytopenia have been reported following injections of SARS-Cov-2 mRNA vaccine. We present the case of a 73-year-old woman with de novo ITP after a first injection of SARS-Cov-2 mRNA vaccine (Moderna vaccine) who experienced a successful rechallenge of SARS-Cov-2 mRNA vaccine (Pfizer vaccine) a few months later.